Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No. It's the prior warrants that we discussed a few weeks ago from 2011. Someone(s) believe that the warrants they have at .52 will be a good sell soon. Can't blame them.
Happy thanksgiving everyone! OncoSec is about ready to kick some major butt!
Holding up pretty good so far.
I think the whining will be put on pause. Even 100million called out Penney yesterday. I thought the world had ended :)
You have to give punit and the team credit. They have set this is pretty well. They really want to uplist and are following INO to a tee.
I'm going to be unbearable to be around for the next 6 weeks. :). So excited. I think oncs has this thing lined up perfectly.
That makes sense. Glad he responded. Thanks Jeff.
Pretty good bounces off the 50 mda so far.
What are you thinking? January through March?
"And the walking man walks"
You blame OncoSec. Lol!!! Get a clue dude.
I hope so. That was my plan. Until then, endless harassing. :)
By the way, I'm still waiting for you to come through in our bet. So far, it's been pretty disappointing. Come on man, get on it!
Why? Don't you know that they have plenty of unused shares available for an offering from the last s-3?
Touché
What does the chart show you John. I just compared it to 2/24 (before our big run last year) and everything seems identical: mfi, rsi, etc. plus we have news this time. What do you think?
Some good covering and consolidation occurring now.
Maybe. Tom123?
No kidding.
Come on. You really believe what you just said?
Actually two officially plus the recent grant to further study with dr heller. So, 2 1/2.
Today's PR illustrates that yet again the increased burn rate that punit mentioned yesterday is due the huge increase in R&D that oncs is pushing. If you are not excited about the direction of the company now, you are an idiot.
We now have three ongoing SRA now!!! Awesome.
About freaking time!!!!!!
I think that increase is due to the two new trials planned. I still think they are going to get a good partnership.
I listened to the section in the Q and A several times and he specifically says that they are excited to announce the trial with a partner. Also, they have everything lined up for the trial starting in December.
I just thought of something in that the partner has a say in when the partnership gets announced as well. Whoever it is agrees with the timing as well. As posted before, if its Merck, Daud is presenting this weekend for them on Melanoma (I've posted the link before) and Merck is presenting on Melanoma and Melanoma Bridge. Therefore, Punit can't say anything and has to be really vague now which of course we all read into.
I find it very interesting that ONCS' monotherapy phase II study is in the combination category for Melanoma Bridge. Announcement?
They still have investors?
Pun it's theme: we are the only one. Love it.
Shut up!!!! Gees!
Yup!!!
He is f inc nailing this!
Definitely 5 milestones!
Lol. Can you read? It is and "or" for the revenue requirement.
http://nasdaq.cchwallstreet.com/nasdaq/main/nasdaq-equityrules/chp_1_1/chp_1_1_4/chp_1_1_4_3/chp_1_1_4_3_7/default.asp
5500. The Nasdaq Capital Market
5501. Preamble to The Nasdaq Capital Market Listing Requirements
This section contains the initial and continued listing requirements and standards for listing a Company's Primary Equity Security on The Nasdaq Capital Market. This section also contains the initial and continued listing requirements for Rights and Warrants; Preferred and Secondary Classes of Common Stock; and Convertible Debt, Rights and Warrants on the Capital Market.
In addition to meeting the quantitative requirements in this section, a Company must meet the requirements of the Rule 5100 Series, the disclosure obligations set forth in the Rule 5200 Series, the Corporate Governance requirements set forth in the Rule 5600 Series, and pay any applicable fees in the Rule 5900 Series. A Company's failure to meet any of the continued listing requirements will be processed in accordance with the provisions set forth in the Rule 5800 Series.
Companies that meet these requirements, but are not listed on the Nasdaq Global Market, are listed on the Nasdaq Capital Market.
Amended by SR-NASDAQ-2009-052 eff. June 16, 2009.
5505. Initial Listing of Primary Equity Securities
A Company applying to list its Primary Equity Security on the Capital Market must meet all of the requirements set forth in Rule 5505(a) and at least one of the Standards in Rule 5505(b).
(a) Initial Listing Requirements for Primary Equity Securities:
(1) (A) Minimum bid price of $4 per share; or
(B) Minimum closing price of $3 per share, if the Company meets the requirements of the Equity or Net Income Standards under Rules 5505(b)(1) or (b)(3), or of $2 per share, if the Company meets the requirements of the Market Value of Listed Securities Standard under Rule 5505(b)(2), provided that in either case the Company must also demonstrate that it has net tangible assets (i.e., total assets less intangible assets and liabilities) in excess of $2 million, if the issuer has been in continuous operation for at least three years; or net tangible assets in excess of $5 million, if the issuer has been in continuous operation for less than three years; or average revenue of at least $6 million for the last three years. A security must meet the applicable closing price requirement for at least five consecutive business days prior to approval.
For purposes of this paragraph (B), net tangible assets or average revenues must be demonstrated on the Company's most recently filed audited financial statements filed with, and satisfying the requirements of, the Commission or Other Regulatory Authority, and which are dated less than 15 months prior to the date of listing.
(2) At least 1,000,000 Publicly Held Shares;
(3) At least 300 Round Lot Holders;
(4) At least three registered and active Market Makers;
(5) In the case of ADRs, at least 400,000 issued.
Absolutely not!!! Over $2 for 5 consecutive days with a certain minimum market cap.
Same rules for dji
Well, Punit is doing 1 on 1 meetings all week.
I can't think of why they would do that.
You are right. Just frustrating. That was a great study, published in in a respected journal, etc. oh well. I'm glad that we are all aware of the study.
Maybe. I just am a bit miffed why they wouldn't PR something that in my opinion is pretty significant. Oh well